Literature DB >> 24760755

Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration.

Raymond F Burk1, Kristina E Hill2, Amy K Motley2, Virginia P Winfrey2, Suguru Kurokawa2, Stuart L Mitchell2, Wanqi Zhang2.   

Abstract

Selenoprotein P (Sepp1) and its receptor, apolipoprotein E receptor 2 (apoER2), account for brain retaining selenium better than other tissues. The primary sources of Sepp1 in plasma and brain are hepatocytes and astrocytes, respectively. ApoER2 is expressed in varying amounts by tissues; within the brain it is expressed primarily by neurons. Knockout of Sepp1 or apoER2 lowers brain selenium from ∼120 to ∼50 ng/g and leads to severe neurodegeneration and death in mild selenium deficiency. Interactions of Sepp1 and apoER2 that protect against this injury have not been characterized. We studied Sepp1, apoER2, and brain selenium in knockout mice. Immunocytochemistry showed that apoER2 mediates Sepp1 uptake at the blood-brain barrier. When Sepp1(-/-) or apoER2(-/-) mice developed severe neurodegeneration caused by mild selenium deficiency, brain selenium was ∼35 ng/g. In extreme selenium deficiency, however, brain selenium of ∼12 ng/g was tolerated when both Sepp1 and apoER2 were intact in the brain. These findings indicate that tandem Sepp1-apoER2 interactions supply selenium for maintenance of brain neurons. One interaction is at the blood-brain barrier, and the other is within the brain. We postulate that Sepp1 inside the blood-brain barrier is taken up by neurons via apoER2, concentrating brain selenium in them. © FASEB.

Entities:  

Keywords:  choroid plexus; megalin

Mesh:

Substances:

Year:  2014        PMID: 24760755      PMCID: PMC4101661          DOI: 10.1096/fj.14-252874

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

1.  Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating.

Authors:  M W Pitts; A V Raman; A C Hashimoto; C Todorovic; R A Nichols; M J Berry
Journal:  Neuroscience       Date:  2012-02-21       Impact factor: 3.590

2.  Maternal-fetal transfer of selenium in the mouse.

Authors:  Raymond F Burk; Gary E Olson; Kristina E Hill; Virginia P Winfrey; Amy K Motley; Suguru Kurokawa
Journal:  FASEB J       Date:  2013-05-07       Impact factor: 5.191

Review 3.  Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy.

Authors:  Reynold Spector; Conrad Johanson
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

4.  ApoER2 function in the establishment and maintenance of retinal synaptic connectivity.

Authors:  Justin H Trotter; Martin Klein; Umesh K Jinwal; Jose F Abisambra; Chad A Dickey; Jeremy Tharkur; Irene Masiulis; Jindong Ding; Kirsten G Locke; Catherine Bowes Rickman; David G Birch; Edwin J Weeber; Joachim Herz
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

5.  The selenium-rich C-terminal domain of mouse selenoprotein P is necessary for the supply of selenium to brain and testis but not for the maintenance of whole body selenium.

Authors:  Kristina E Hill; Jiadong Zhou; Lori M Austin; Amy K Motley; Amy-Joan L Ham; Gary E Olson; John F Atkins; Raymond F Gesteland; Raymond F Burk
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

6.  Deletion of selenoprotein P alters distribution of selenium in the mouse.

Authors:  Kristina E Hill; Jiadong Zhou; Wendy J McMahan; Amy K Motley; John F Atkins; Raymond F Gesteland; Raymond F Burk
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

7.  Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.

Authors:  Eva K Wirth; Marcus Conrad; Jochen Winterer; Christian Wozny; Bradley A Carlson; Stephan Roth; Dietmar Schmitz; Georg W Bornkamm; Vincenzo Coppola; Lino Tessarollo; Lutz Schomburg; Josef Köhrle; Dolph L Hatfield; Ulrich Schweizer
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

8.  Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP).

Authors:  G Zheng; D R Bachinsky; I Stamenkovic; D K Strickland; D Brown; G Andres; R T McCluskey
Journal:  J Histochem Cytochem       Date:  1994-04       Impact factor: 2.479

9.  Isoform-specific binding of selenoprotein P to the β-propeller domain of apolipoprotein E receptor 2 mediates selenium supply.

Authors:  Suguru Kurokawa; Frederick P Bellinger; Kristina E Hill; Raymond F Burk; Marla J Berry
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

10.  Evidence for specific selenium target tissues and new biologically important selenoproteins.

Authors:  D Behne; H Hilmert; S Scheid; H Gessner; W Elger
Journal:  Biochim Biophys Acta       Date:  1988-07-14
View more
  43 in total

1.  Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.

Authors:  Ranjeet K Sinha; Xia V Yang; José A Fernández; Xiao Xu; Laurent O Mosnier; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

Review 2.  Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins.

Authors:  Ting Gong; Daniel J Torres; Marla J Berry; Matthew W Pitts
Journal:  Free Radic Biol Med       Date:  2018-03-05       Impact factor: 7.376

Review 3.  The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease.

Authors:  Courtney Lane-Donovan; Joachim Herz
Journal:  J Lipid Res       Date:  2017-03-14       Impact factor: 5.922

4.  Increased selenoprotein P in choroid plexus and cerebrospinal fluid in Alzheimer's disease brain.

Authors:  Rachel H L H Rueli; Arlene C Parubrub; Andrea S T Dewing; Ann C Hashimoto; Miyoko T Bellinger; Edwin J Weeber; Jane H Uyehara-Lock; Lon R White; Marla J Berry; Frederick P Bellinger
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 5.  Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins.

Authors:  Carmine Rocca; Teresa Pasqua; Loubna Boukhzar; Youssef Anouar; Tommaso Angelone
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

Review 6.  Parasites, nutrition, immune responses and biology of metabolic tissues.

Authors:  T Shea-Donohue; B Qin; A Smith
Journal:  Parasite Immunol       Date:  2017-03-22       Impact factor: 2.280

7.  Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations.

Authors:  Mark A Greenough; Darius J R Lane; Rachelle Balez; Helena Targa Dias Anastacio; Zhiwen Zeng; Katherine Ganio; Christopher A McDevitt; Karla Acevedo; Abdel Ali Belaidi; Jari Koistinaho; Lezanne Ooi; Scott Ayton; Ashley I Bush
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 15.828

8.  Inhibition of selenoprotein synthesis by Zika virus may contribute to congenital Zika syndrome and microcephaly by mimicking SELENOP knockout and the genetic disease PCCA.

Authors:  Gabrielle P Dailey; Lakmini S Premadasa; Jan A Ruzicka; Ethan Will Taylor
Journal:  BBA Adv       Date:  2021-08-12

Review 9.  Selenoproteins in nervous system development and function.

Authors:  Matthew W Pitts; China N Byrns; Ashley N Ogawa-Wong; Penny Kremer; Marla J Berry
Journal:  Biol Trace Elem Res       Date:  2014-07-01       Impact factor: 3.738

10.  Juvenile Selenium Deficiency Impairs Cognition, Sensorimotor Gating, and Energy Homeostasis in Mice.

Authors:  Victor W Kilonzo; Alexandru R Sasuclark; Daniel J Torres; Celine Coyle; Jennifer M Pilat; Christopher S Williams; Matthew W Pitts
Journal:  Front Nutr       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.